Skip to main content

Collection Open for Submissions

New Content ItemExtracellular vesicles in cancer progression

Guest Edited by: Orazio Fortunato, Irina Matei and Chunlin Ou

Editors' Picks

New Content ItemCharacterization and comparison of human glioblastoma models

Schulz et al. characterized two human GBM models (U87-luc2, U251-RedFLuc) in vitro and in vivo, showing that they recapitulate different aspects of GBM heterogeneity that need to be considered in preclinical research.

New Content ItemPhantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system

Fragoso Costa et al. determined the lowest 18F-FDG PET acquisition time without loss of diagnostic information and optimised image reconstruction parameters by phantom imaging.

New Content ItemInhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor

Montagna et al. investigated the hyperprogressive-cancer disease in two murine tumors widely different regarding immunogenicity and in models of local recurrences and metastases. 

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!


Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions

Aims and Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

September - Childhood Cancer Awareness Month

July - Sarcoma Awareness Month

Childhood Cancer awareness month runs for the whole of September. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents. Survival rates for most childhood cancers have improved in recent decades, however many children will have long-term side-effects that may significantly impact their lives forever. In the paper below Masumoto et al. reported game-based learning programs as tools that can be effectively applied to survivorship care as a new modality of patient education.

New Content ItemA pilot study of game-based learning programs for childhood cancer survivors

Join our Editorial Board

New Content Item

Interested in joining the editorial board of BMC Cancer?

More information and how to apply can be found here. We are looking forward to hearing from you.

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact
    4.638 - 2-year Impact Factor (2021)
    4.672 - 5-year Impact Factor (2021)
    1.308 - SNIP (Source Normalized Impact per Paper)
    1.134 - SJR SCImago Journal Rank (SJR)

    37 days to first decision for all manuscripts (Median)
    65 days to first decision for reviewed manuscripts only (Median)

    6,897,358 Downloads (2021)
    4,517 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal